Prognostic value of 99mTc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy

Journal of Nuclear Medicine

Volumn 43, Issue 6, 2002, Pages 745-751

  Sciuto, Rosa ^a   Pasqualoni, Rosella ^a   Bergomi, Serenella ^a   Petrilli, Germana ^a   Vici, Patrizia ^a   Belli, Franca ^a   Botti, Claudio ^a   Mottolese, Marcella ^a   Maini, Carlo L ^a  

^a NONE   (Italy)

Author keywords

99mTc sestamibi; Breast cancer; Multidrug resistance; Neoadjuvant chemotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DOSE RESPONSE; FEMALE; HIGH RISK PATIENT; HUMAN; MULTIDRUG RESISTANCE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SAMPLING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; MASTECTOMY, RADICAL; MIDDLE AGED; NEOADJUVANT THERAPY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036083688     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. MDR1 gene expression in solid tumors
2. Expression of a multidrug resistance gene in human cancer
3. Expression of MDR1 and GST-p in human breast tumors: Comparison to in vitro chemosensitivity
4. Clinical multidrug resistance in cancer: A multifactorial problem
5. Drug-induced DNA damage and tumor chemosensitivity
6. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line
7. Expression of drug resistance proteins in breast cancer, in relation to chemotherapy
8. Biology of the multidrug resistance-associated protein, MRP
9. Expression of a multidrug resistance gene in human tumors and tissues
10. MRP and MDR1 gene expression in primary breast carcinoma
11. Clinical significance of the increased multidrug resistance-associated protein (MRP) gene expression in patients with primary breast cancer
12. Influence of the heterogeneity of P-glycoprotein expression on technetium-99m-MIB1 uptake in breast cancer
13. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction
14. Quantitative immunocytochemical assays of p-glycoprotein in breast carcinomas: Correlations to messenger RNA expression and to immunohistochemical prognostic indicators
15. Methods to detect p-glycoprotein-associated multidrug resistance in patients' tumors: Consensus recommendations
16. Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines
17. Use of myocardial agents for tumor diagnosis: A success story?
18. 99mTc-sestamibi breast imaging: Multicenter trial results
19. Functional imaging of multidrug-resistant P-glycoprotein with an organo-technetium complex
20. 99mTc-MIBI in cells with P-glycoprotein-mediated and MRP-associated multidrug resistant phenotypes
21. Visualization of multidrug resistance in vivo
22. 99mTc-sestamibi uptake in malignant tumors
23. 99mTc-sesta-MIBI and prognostic factors of breast cancer
24. Primary breast cancer imaging with technetium-99m-sestamibi and its relation with P-glycoprotein overexpression
25. 99mTc-sestamibi scan in untreated breast cancer
26. The measurements of observer agreement for categorical data
27. Search for specific inhibitors of multidrug resistance in cancer
28. Resistance to anticancer drugs: Are we ready to use biologic information for the treatment of patients with cancer?
29. Uptake of technetium-99m-tetrofosmin, technetium-99m MIBI and thallium-201 in tumor cell lines
30. Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma
31. Multidrug resistance in breast cancer: A meta-analysis of MDR/gp 170 expression and its possible functional significance
32. 99mTc-sestamibi is a substrate for P-glycoprotein-mediated and multidrug resistance associated protein
33. Tumor clearance of technetium-99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer
34. 99mTc-MIBI scintigraphy as an indicator of the chemosensitivity of anthracyclines in patients with breast cancer
35. Sequential functional imaging with technetium 99m hexakis-2-methoxy-isobutilisonitrile and indium-111-octreotide: Can we predict the response to chemotherapy in small cell lung cancer?
36. Evaluation of tumor metabolism and multidrug-resistance in patients with treated malignant lymphomas
37. The effect of chemotherapy on the uptake of technetium sestamibi in breast cancer